Showing results (61-70 of 106) with videos related to
Sort By:
Pageof 11
American Journal of Human Genetics|August 3, 2024
Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing datasetAimee L Davidson, Kyriaki Michailidou, Michael T Parsons, et al.Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.Nature Communications|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.Genome Medicine|May 18, 2022
Breast cancer risks associated with missense variants in breast cancer susceptibility genesLeila Dorling, Sara Carvalho, Jamie Allen, et al.Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.Journal of Medical Genetics|July 14, 2023
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in IsraelHagai Levi, Shai Carmi, Saharon Rosset, et al.Communications Biology|January 19, 2022
Rare germline copy number variants (CNVs) and breast cancer riskJoe Dennis, Jonathan P Tyrer, Logan C Walker, et al.Cancer Medicine|July 4, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.Research Square|February 24, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.Pageof 11